Old Web
English
Sign In
Acemap
>
authorDetail
>
Yifan Zhang
Yifan Zhang
Novartis
Medicine
Gastroenterology
Internal medicine
Ruxolitinib
Polycythemia vera
2
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase II, Randomized, Multicenter, Open-Label Study Evaluating the Effect of Crizanlizumab and Standard of Care (SoC) Versus Standard of Care Alone on Renal Function in Patients with Chronic Kidney Disease Due to Sickle Cell Nephropathy (STEADFAST)
2021
Blood
Santosh L. Saraf
Kenneth I. Ataga
Vimal K. Derebail
Claire C. Sharpe
Adlette Inati
Jeffrey D. Lebensburger
Laurie Debonnett
Yifan Zhang
Pablo Bartolucci
Show All
Source
Cite
Save
Citations (0)
Long-Term Effect of Ruxolitinib (RUX) in Inadequately Controlled Polycythemia Vera (PV) without Splenomegaly: 5-Year Results from the Phase 3 Response-2 Study
2020
Blood
Francesco Passamonti
Francesca Palandri
Guray Saydam
Miklós Egyed
Jeannie Callum
Timothy Devos
Serdar Sivgin
Paola Guglielmelli
Alessandro M. Vannucchi
Evren Zor
Geralyn Gilotti
Yifan Zhang
Martin Griesshammer
Show All
Source
Cite
Save
Citations (3)
1
map